Australia markets closed

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.7500+0.0100 (+1.35%)
At close: 02:40PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
236.56
236.56
235.517
171.194
110
Operating expenses
Research development
164.312
212.297
275.388
36.704
13.286
Selling general and administrative
418.113
711.212
299.734
335.26
306.031
Total operating expenses
582.425
923.509
575.122
371.964
319.317
Operating income or loss
-345.865
-686.949
-339.605
-200.77
-209.317
Interest expense
64.22
59.448
209.787
367.028
942.933
Total other income/expenses net
-168.898
2,153
3,038
-6,198
4,567
Income before tax
-828.983
1,157
2,444
-6,765
3,414
Income from continuing operations
-828.983
1,157
2,444
-6,765
3,414
Net income
-774.691
1,024
2,227
-6,765
2,732
Net income available to common shareholders
-774.691
1,024
2,227
-6,765
2,732
Basic EPS
0.29
0.29
0.71
-3.38
3.00
Diluted EPS
0.29
0.29
0.71
-3.38
3.00
Basic average shares
3,537
3,537
3,136
2,008
939.897
Diluted average shares
3,537
3,537
3,136
2,008
939.897